Molson Coors Beverage Company - Class B

NYSE: TAP
$59.56
+$2.83 (+5.0%)
Closing Price on November 8, 2024

TAP Articles

Jefferies is focused on companies it feels will see a huge benefit from the pent-up demand. These five stocks make sense for growth investors looking to play the resurgence, as the companies may be...
Monday's top analyst upgrades and downgrades included Abercrombie & Fitch, Cabot Oil, Dollar General, L Brands, MGM Resorts, ViacomCBS and Unity Software.
Monday's top analyst upgrades and downgrades included AT&T, Airbnb, Boeing, Chubb, Coca-Cola, DoorDash, Expedia, Goldman Sachs and McDonald's.
Tuesday's top analyst upgrades and downgrades included Clorox, Coca-Cola, Colgate-Palmolive, Garmin, Jabil, Newell Brands, Palo Alto Networks, Pepsico, Procter & Gamble and Smartsheet.
24/7 Wall St. has tracked a group of companies that have simply refused to participate in the stock market upside.
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
When so many people have been advised or ordered to stay home, it's reasonable to expect that the goods those people will be buying are consumer staples like food. But even some of these stocks are...
24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued again.
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
The cannabis industry got another shock when Aurora Cannabis announced that its founder and chief executive, Terry Booth, would retire. He is the third high-profile CEO of a cannabis company to lose...
Investors of Aurora Cannabis, like investors everywhere, are an impatient lot. Wall Street expects profits, and none of these marijuana companies is anywhere near profitability.
As the bad news piled up for CannTrust last year, the rest of the cannabis industry also imploded. What to expect from CannTrust in 2020 is a glass either half-empty or half-full.
Canada-based pot grower Organigram had the same up-in-smoke year as most of the country's other cannabis producers. The company may get back on track this year.
Marijuana stocks like Tilray were beaten up badly in 2019. Will 2020 get the industry back in the black?